Notably, both stop-gain and frameshift mutations in SORL1 are exclusively observed in AD patients (Holstege et al., 2017; Raghavan et al., 2018), providing direct genetic evidence that truncating variants of SORL1 are highly penetrant. The gene discussed is SORL1; the disease is Alzheimer disease.